0001193125-22-092360 Sample Contracts
Forte Biosciences, Inc. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • April 1st, 2022 • Forte Biosciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 1st, 2022 Company Industry JurisdictionForte Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Agent”) as follows: